Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 4;15(13):3030.
doi: 10.3390/nu15133030.

Kiwifruit's Allergy in Children: What Do We Know?

Affiliations
Review

Kiwifruit's Allergy in Children: What Do We Know?

Ivana Bringheli et al. Nutrients. .

Abstract

Kiwifruit allergy is an emerging pathological condition in both general and pediatric populations with a wide range of symptoms linked to variable molecular patterns, justifying systemic and cross-reactions with other allergens (i.e., latex, pollen, and fruit). Skin prick test (SPT), specific serum IgE (Act d 1, Act d 2, Act d 5, Act d 8, and Act d 10) directed against five out of thirteen molecular allergens described in the literature, and oral test challenge with kiwifruit are available for defining diagnosis. The management is similar to that of other food allergies, mostly based on an elimination diet. Although kiwi allergy has been on the rise in recent years, few studies have evaluated the clinical characteristics and methods of investigating this form of allergy. Data collected so far show severe allergic reaction to be more frequent in children compared to adults. Therefore, the aim of this review is to collect the reported clinical features and the available association with specific molecular patterns of recognition to better understand how to manage these patients and improve daily clinical practice.

Keywords: Act d 1; allergy; children; cross-reactivity; kiwifruit.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Diagnostic flowchart. Patient personal histories of severe reactions need to be tested via SPT, RAST, and CRD. Anaphylaxis is indicated by “severe reaction”. In this case, if the laboratory test result is positive, a food allergy is claimed; the timing for the challenge test is decided after considering the clinical response and the outcome of the CRD test. If the serological exams are negative, a focused elimination diet should follow. Based on the diet change response, the challenge test becomes worthy in revealing the diagnosis. The diagnostic process is similar in patients with immediate nonsevere reactions after kiwifruit ingestion, such as rash, urticaria, dyspnea, intense coughing, swelling of tongue, lips, and extremities, and itching. Apart from the results of the diagnostic tools, an elimination diet should be implemented. If relief from symptoms is achieved, the challenge test should be performed; on the contrary, it is possible to reintroduce the food, especially with negative serum diagnostic test results (including the CRD) [40]. In this case, there is no evidence to claim the specific kiwifruit allergy.

References

    1. Fine A.J. Hypersensitivity reaction to kiwi fruit (Chinese gooseberry, Actinidia chinensis) J. Allergy Clin. Immunol. 1981;68:235–237. doi: 10.1016/0091-6749(81)90189-5. - DOI - PubMed
    1. U.S. Department of Agriculture Agricultural Research Service. [(accessed on 17 April 2023)]; Available online: https://fdc.nal.usda.gov/fdc-app.html#/food-details/168153/nutrients.
    1. Nishiyama I. Fruits of the actinidia genus. Adv. Food Nutr. Res. 2007;52:293–324. - PubMed
    1. Rancé F., Grandmottet X., Grandjean H. Prevalence and main characteristics of schoolchildren diagnosed with food allergies in France. Clin. Exp. Allergy. 2005;35:167–172. doi: 10.1111/j.1365-2222.2005.02162.x. - DOI - PubMed
    1. Gall H., Kalveram K.J., Forck G., Sterry W. Kiwi fruit allergy: A new birch pollen-associated food allergy. J. Allergy Clin. Immunol. 1994;94:70–76. doi: 10.1016/0091-6749(94)90073-6. - DOI - PubMed